SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-007172
Filing Date
2021-01-25
Accepted
2021-01-25 16:18:00
Documents
4
Period of Report
2021-01-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213819d1_8k.htm 8-K 22815
2 EXHIBIT 99.1 tm213819d1_ex99-1.htm EX-99.1 10775
3 GRAPHIC tm213819d1_8kimg001.jpg GRAPHIC 15620
4 GRAPHIC tm213819d1_ex99-1img001.jpg GRAPHIC 8211
  Complete submission text file 0001104659-21-007172.txt   67970
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 21549828
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences